David Wood

Borden Ladner Gervais LLP


David is co-chair of Borden Ladner Gervais' Cannabis Industry Focus Group and his practice focuses on intellectual property and regulatory law. His practice is focused entirely on work with psychedelics, entheogens, dissociative anaesthetics and other controlled substances, and on the global cannabis industry. David works with innovators in the emerging psychedelics space and in the global cannabis industry. David holds a PhD in structural biochemistry, which provides useful insight and perspective when advising clients.